查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1490308

精準醫療市場，按類型、適應症、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Precision Medicine Market, By Type, By Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年精準醫療市場規模為301.542億美元，2024年至2032年複合年成長率為12.40%。

精準醫療市場-市場動態

精準醫學利用遺傳學和蛋白質進行個人化治療，推動市場成長

精準醫學利用患者的基因和蛋白質來創建專門針對其特定疾病的個人化治療。由於精準醫學領域的單核苷酸多態性和微陣列/生物晶片等關鍵發現，預計市場在不久的將來將出現顯著成長。研究人類基因組對於精準醫學的進步至關重要，並且能夠透過分析每位患者的遺傳學、分子組成和臨床特徵來徹底改變每位患者的醫療護理，從而為治療疾病提供量身定做的治療方法。上述因素預計將在未來幾年推動精準醫療的需求。此外，預計癌症病例的增加將推動對個人化治療和檢測的精準醫療的需求，從而對市場擴張產生積極影響。 2018年，美國新診斷出近170萬癌症病例。

精準醫療市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 12.40% 左右的複合年成長率成長

根據類型細分，預計抑制劑藥物將在 2023 年顯示最大的市場佔有率

根據適應症細分，腫瘤學是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

精準醫療市場-細分分析：

全球精準醫學市場根據類型、適應症、最終用戶和地區進行細分。

市場依類型分為三類：抑制劑藥物、單株抗體、細胞和基因療法、抗病毒和抗逆轉錄病毒藥物以及其他治療產品。 2023年，由於抑制劑藥物有效性的提高以及大量商業批准藥物等因素，抑制劑藥物類別將佔據最大的市場佔有率。此外，抑制劑藥物涵蓋廣泛的適應症，包括腫瘤學和罕見疾病。

市場依適應症分為兩類：腫瘤、罕見疾病、傳染病、血液疾病和其他適應症。從 2023 年到 2032 年，腫瘤學類別在市場上佔據主導地位。然而，由於精準醫療的可用性增加，中樞神經系統是預測期內成長最快的類別。中樞神經系統標靶藥物預測（CNS TAP）系統的開發是為了幫助根據患者特異性基因組資料選擇精準醫學療法。

精準醫療市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。就收入而言，北美將在 2023 年成為最大的市佔率持有地區，並預計在未來幾年將繼續保持這一地位。癌症發病率的增加以及該地區知名市場參與者的存在預計將成為推動該地區市場擴張的關鍵驅動力。此外，對精準醫療的需求主要是由政府的積極舉措和增加投資來創造最佳疾病管理的新穎解決方案所推動的。

亞太地區精準醫療市場預計在 2023 年至 2032 年間將以最快的複合年成長率發展。此外，中國精準醫療產業市場佔有率最大，而印度精準醫療市場在亞太地區成長最快。

精準醫療市場-競爭格局：

主要市場參與者正在大力投資研發以擴展其產品線，這將有助於精準醫療市場進一步成長。市場參與者也在尋求策略措施來擴大其全球足跡，包括新產品發布、併購、合約協議、增加投資以及與其他企業的合作。精準醫療競爭對手必須提供具有成本效益的產品，才能在競爭日益激烈且不斷上升的市場環境中擴張和生存。

最近的發展：

2022 年 1 月，阿斯特捷利康和 Scorpion Therapeutics 同意合作開發、行銷和發現針對迄今為止難以靶向的癌症蛋白的精準療法。它可以透過克服靶向轉錄因子和覆蓋服務不足的患者群體的挑戰來改變腫瘤治療。它專注於稱為轉錄因子的蛋白質，它調節重要的生理過程和基因表現。

目錄

第1章：精準醫療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的精準醫療市場片段
    • 按適應症分類的精準醫療市場片段
    • 最終用戶的精準醫療市場片段
    • 按國家/地區分類的精準醫療市場摘要
    • 按地區分類的精準醫療市場片段
  • 競爭洞察

第 3 章：精準醫學主要市場趨勢

  • 精準醫療市場促進因素
    • 市場促進因素的影響分析
  • 精準醫療市場限制
    • 市場限制影響分析
  • 精準醫療市場機會
  • 精準醫療市場未來趨勢

第 4 章：精準醫療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：精準醫療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：精準醫療市場格局

  • 2023 年精準醫療市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：精準醫療市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 抑制劑藥物
    • 單株抗體
    • 細胞與基因治療
    • 抗病毒和抗逆轉錄病毒藥物
    • 其他治療產品

第 8 章：精準醫療市場 - 依適應症分類

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 腫瘤學
    • 罕見疾病
    • 傳染性疾病
    • 血液系統疾病
    • 其他適應症

第 9 章：精準醫療市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 家庭護理設置

第 10 章：精準醫療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美精準醫療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按指標）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲精準醫療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模與預測（按指標）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區精準醫療主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（依指標）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲精準醫療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按指標）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲精準醫療主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（依指標）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第11章：關鍵供應商分析-精準醫療產業

  • 競爭儀表板
  • 公司簡介
    • Hoffmann-La Roche Ltd. (Switzerland)
    • Novartis AG (Switzerland)
    • Pfizer Inc. (US)
    • Bristol Myers Squibb (US)
    • AstraZeneca (UK)
    • Gilead Sciences, Inc. (US)
    • AbbVie Inc. (US)
    • Eli Lilly and Company (US)
    • GlaxoSmithKline plc (UK)
    • Sanofi (France)
    • Johnson & Johnson (US)
    • Merck KGaA (Germany)
    • Amgen, Inc. (US)
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2882

REPORT HIGHLIGHT

Precision Medicine Market size was valued at USD 30,154.2 Million in 2023, expanding at a CAGR of 12.40% from 2024 to 2032.

Precision medicine, also known as personalized medicine or individualized medicine, is a method of healthcare that considers individual differences in genes, environment, and lifestyle when developing medical treatment plans and actions. Rather of taking a one-size-fits-all strategy, precision medicine seeks to personalize medical decisions and treatments to the unique characteristics of each patient.

Precision Medicine Market- Market Dynamics

Precision Medicine Utilizes Genetics and Proteins for Personalized Treatments, Driving Market Growth

Precision medicine uses the patient's genes and proteins to create a personalized treatment specifically tailored to treat their specific disease. Due to key findings like single nucleotide polymorphism and microarray/biochips in the realm of precision medicine, the market is anticipated to see significant growth in the near future. Studying the human genome is crucial for the advancement of precision medicine and has the ability to revolutionize medical care for each patient by analyzing their genetics, molecular makeup, and clinical features to provide tailored treatments for curing diseases. The mentioned factors are expected to boost the demand for precision medicine in the coming years. In addition, an increase in cancer cases is projected to drive the need for precision medicine for individualized treatments and testing, positively impacting market expansion. In the United States in 2018, close to 1.7 Million new cancer cases were diagnosed.

Precision Medicine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.40% over the forecast period (2024-2032)

Based on Type segmentation, Inhibitor drugs was predicted to show maximum market share in the year 2023

Based on Indication segmentation, Oncology was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Precision Medicine Market- Segmentation Analysis:

The Global Precision Medicine Market is segmented on the basis of Type, Indication, End User, and Region.

The market is divided into three categories based on Type: Inhibitor drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-retroviral drugs and Other Therapeutic Products. In 2023, the inhibitor drugs category accounted for the biggest share of the market due to factors such as increased effectiveness of inhibitor pharmaceuticals and a significant number of commercially approved drugs. Furthermore, inhibitor medications cover a wide range of indications, including oncology and uncommon illnesses.

The market is divided into two categories based on Indication: Oncology, Rare Diseases, Infectious diseases, Hematological disorders, and Other indications. The oncology category dominated the market from 2023 to 2032. Precision oncology is a rapidly emerging and promising research subject that allows for individualized therapy based on an individual's molecular and genetic traits. However, the central nervous system is the fastest-growing category over the predicted period, owing to the increased availability of precision medicine. The central nervous system Targeted Agent Prediction (CNS TAP) System was developed to help in the selection of precision medicine therapies based on patient-specific genomic data.

Precision Medicine Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. In terms of revenue, North America is the largest market share holding region in 2023 and is expected to continue its position in the future years. The increasing frequency of cancer, as well as the presence of prominent market players in the region, are projected to be key drivers driving market expansion in the region. Furthermore, demand for precision medicine is being driven mostly by positive government initiatives and increased investment in creating novel solutions for optimal illness management.

The Asia-Pacific precision medicine market is predicted to develop at the quickest CAGR between 2023 and 2032. This is owing to the availability of low-cost clinical trials for cutting-edge precision medicine, as well as significant investments in healthcare facilities and technology. Furthermore, the Chinese precision medicine industry had the biggest market share, while India's precision medicine market was the fastest-growing in the Asia-Pacific region.

Precision Medicine Market- Competitive Landscape:

Major market players are investing heavily in research and development to extend their product lines, which will help the precision medicine market grow even more. Market participants are also pursuing strategic measures to expand their global footprint, including new product launches, mergers and acquisitions, contractual agreements, higher investments, and collaboration with other businesses. Precision medicine competitors must provide cost-effective products in order to expand and survive in an increasingly competitive and rising market environment.

Recent Developments:

In January 2022, AstraZeneca and Scorpion Therapeutics have agreed to collaborate on the development, marketing, and discovery of precision therapies targeting hitherto difficult-to-target cancer proteins. It could transform oncology treatment by overcoming the challenges of targeting transcription factors and reaching underserved patient populations. It focuses on proteins known as transcription factors, which regulate important physiological processes and gene expression.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PRECISION MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Hoffmann-La Roche Ltd. (Switzerland)

Novartis AG (Switzerland)

Pfizer Inc. (US)

Bristol Myers Squibb (US)

AstraZeneca (UK)

Gilead Sciences, Inc. (US)

AbbVie Inc. (US)

Eli Lilly and Company (US)

GlaxoSmithKline plc (UK)

Sanofi (France)

Johnson & Johnson (US)

Merck KGaA (Germany)

Amgen, Inc. (US)

Others

GLOBAL PRECISION MEDICINE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Inhibitor drugs
  • Monoclonal Antibodies
  • Cell & Gene Therapy
  • Antiviral & Anti-retroviral drugs
  • Other Therapeutic Products

GLOBAL PRECISION MEDICINE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Rare Diseases
  • Infectious diseases
  • Hematological disorders
  • Other indications

GLOBAL PRECISION MEDICINE MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Home care settings

GLOBAL PRECISION MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Precision Medicine Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Precision Medicine Market Snippet by Type
    • 2.1.2.Precision Medicine Market Snippet by Indication
    • 2.1.3.Precision Medicine Market Snippet by End User
    • 2.1.4.Precision Medicine Market Snippet by Country
    • 2.1.5.Precision Medicine Market Snippet by Region
  • 2.2.Competitive Insights

3.Precision Medicine Key Market Trends

  • 3.1.Precision Medicine Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Precision Medicine Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Precision Medicine Market Opportunities
  • 3.4.Precision Medicine Market Future Trends

4.Precision Medicine Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Precision Medicine Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Precision Medicine Market Landscape

  • 6.1.Precision Medicine Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Precision Medicine Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Inhibitor drugs
    • 7.1.3.Monoclonal Antibodies
    • 7.1.4.Cell & Gene Therapy
    • 7.1.5.Antiviral & Anti-retroviral drugs
    • 7.1.6.Other Therapeutic Products

8.Precision Medicine Market - By Indication

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 8.1.2.Oncology
    • 8.1.3.Rare Diseases
    • 8.1.4.Infectious diseases
    • 8.1.5.Hematological disorders
    • 8.1.6.Other indications

9.Precision Medicine Market - By End User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2.Hospitals and Clinics
    • 9.1.3.Home care settings

10.Precision Medicine Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Precision Medicine Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Precision Medicine Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Precision Medicine Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Precision Medicine Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Precision Medicine Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Precision Medicine Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Hoffmann-La Roche Ltd. (Switzerland)
    • 11.2.2.Novartis AG (Switzerland)
    • 11.2.3.Pfizer Inc. (US)
    • 11.2.4.Bristol Myers Squibb (US)
    • 11.2.5.AstraZeneca (UK)
    • 11.2.6.Gilead Sciences, Inc. (US)
    • 11.2.7.AbbVie Inc. (US)
    • 11.2.8.Eli Lilly and Company (US)
    • 11.2.9.GlaxoSmithKline plc (UK)
    • 11.2.10.Sanofi (France)
    • 11.2.11.Johnson & Johnson (US)
    • 11.2.12.Merck KGaA (Germany)
    • 11.2.13.Amgen, Inc. (US)
    • 11.2.14.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Precision Medicine Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Precision Medicine Market, by Type 2019-2032 (USD Million)
  • TABLE Precision Medicine Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Precision Medicine Market, by Indication 2019-2032 (USD Million)
  • TABLE Precision Medicine Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Precision Medicine Market, by End User 2019-2032 (USD Million)
  • TABLE Precision Medicine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Precision Medicine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Precision Medicine Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Precision Medicine Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Precision Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Precision Medicine Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Precision Medicine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Precision Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Medicine Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Medicine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Precision Medicine Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Precision Medicine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Precision Medicine Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Medicine Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Medicine Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Medicine Market, by End User, 2019-2032 (USD Million)